
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
Guangbing Xiong, Chang Liu, Gang Yang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 181
Guangbing Xiong, Chang Liu, Gang Yang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 181
Showing 1-25 of 181 citing articles:
Roles of IFN-γ in tumor progression and regression: a review
Dragica Jorgovanović, Mengjia Song, Liping Wang, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 868
Dragica Jorgovanović, Mengjia Song, Liping Wang, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 868
TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
Jin Ma, Gonzalo Sánchez‐Duffhues, Marie‐José Goumans, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 191
Jin Ma, Gonzalo Sánchez‐Duffhues, Marie‐José Goumans, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 191
Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer
Alexandre F. Aissa, Abul Bashar Mir Md. Khademul Islam, Majd Ariss, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 190
Alexandre F. Aissa, Abul Bashar Mir Md. Khademul Islam, Majd Ariss, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 190
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 178
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 178
Long non-coding RNAs regulate drug resistance in cancer
Kaisheng Liu, Lin Gao, Xiaoshi Ma, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 165
Kaisheng Liu, Lin Gao, Xiaoshi Ma, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 165
Molecular and cellular paradigms of multidrug resistance in cancer
Foram U. Vaidya, Abu Sufiyan Chhipa, Vinita Mishra, et al.
Cancer Reports (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 161
Foram U. Vaidya, Abu Sufiyan Chhipa, Vinita Mishra, et al.
Cancer Reports (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 161
A Systematic Review of Artificial Intelligence Techniques in Cancer Prediction and Diagnosis
Yogesh Kumar, Surbhi Gupta, Ruchi Singla, et al.
Archives of Computational Methods in Engineering (2021) Vol. 29, Iss. 4, pp. 2043-2070
Open Access | Times Cited: 161
Yogesh Kumar, Surbhi Gupta, Ruchi Singla, et al.
Archives of Computational Methods in Engineering (2021) Vol. 29, Iss. 4, pp. 2043-2070
Open Access | Times Cited: 161
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Tejeshwar Jain, Prateek Sharma, Abhi C. Are, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 132
Tejeshwar Jain, Prateek Sharma, Abhi C. Are, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 132
Target c-Myc to treat pancreatic cancer
Moein Ala
Cancer Biology & Therapy (2022) Vol. 23, Iss. 1, pp. 34-50
Open Access | Times Cited: 91
Moein Ala
Cancer Biology & Therapy (2022) Vol. 23, Iss. 1, pp. 34-50
Open Access | Times Cited: 91
Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
Chang‐Feng Deng, Neng Zhu, Tanjun Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 77
Chang‐Feng Deng, Neng Zhu, Tanjun Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 77
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
Mengyu Feng, Guangbing Xiong, Zhe Cao, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 110
Mengyu Feng, Guangbing Xiong, Zhe Cao, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 110
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
Wangkai Xie, Man Chu, Gendi Song, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 303-318
Closed Access | Times Cited: 96
Wangkai Xie, Man Chu, Gendi Song, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 303-318
Closed Access | Times Cited: 96
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8075-8095
Open Access | Times Cited: 93
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8075-8095
Open Access | Times Cited: 93
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
Faroogh Marofi, Alaa Sadeq Al-Awad, Heshu Sulaiman Rahman, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 88
Faroogh Marofi, Alaa Sadeq Al-Awad, Heshu Sulaiman Rahman, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 88
LOX-1 and cancer: an indissoluble liaison
Michela Murdocca, Claudia De Masi, Sabina Pucci, et al.
Cancer Gene Therapy (2021) Vol. 28, Iss. 10-11, pp. 1088-1098
Open Access | Times Cited: 85
Michela Murdocca, Claudia De Masi, Sabina Pucci, et al.
Cancer Gene Therapy (2021) Vol. 28, Iss. 10-11, pp. 1088-1098
Open Access | Times Cited: 85
Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy
Dorota Komar, Przemysław Juszczyński
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 80
Dorota Komar, Przemysław Juszczyński
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 80
Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
Robert O’Neill, Alina Stoita
World Journal of Gastroenterology (2021) Vol. 27, Iss. 26, pp. 4045-4087
Open Access | Times Cited: 78
Robert O’Neill, Alina Stoita
World Journal of Gastroenterology (2021) Vol. 27, Iss. 26, pp. 4045-4087
Open Access | Times Cited: 78
Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance
Saeedeh Keyvani‐Ghamsari, Khatereh Khorsandi, Azhar Rasul, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Saeedeh Keyvani‐Ghamsari, Khatereh Khorsandi, Azhar Rasul, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Lynch Syndrome and MSI-H Cancers: From Mechanisms to “Off-The-Shelf” Cancer Vaccines
Vladimir Roudko, Cansu Cimen Bozkus, Benjamin Greenbaum, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 70
Vladimir Roudko, Cansu Cimen Bozkus, Benjamin Greenbaum, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 70
Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
Saikat Ghosh, Ankit Javia, Saritha Shetty, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 27-58
Closed Access | Times Cited: 68
Saikat Ghosh, Ankit Javia, Saritha Shetty, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 27-58
Closed Access | Times Cited: 68
Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models
Gang Yang, Wenfang Guan, Zhe Cao, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 12, pp. 3383-3396
Open Access | Times Cited: 62
Gang Yang, Wenfang Guan, Zhe Cao, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 12, pp. 3383-3396
Open Access | Times Cited: 62
The role of microbiomes in gastrointestinal cancers: new insights
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 16
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 16
Surface plasmon resonance biosensor using hydrogel-AuNP supramolecular spheres for determination of prostate cancer-derived exosomes
Wenqin Chen, Jia Li, Xiaotong Wei, et al.
Microchimica Acta (2020) Vol. 187, Iss. 11
Closed Access | Times Cited: 62
Wenqin Chen, Jia Li, Xiaotong Wei, et al.
Microchimica Acta (2020) Vol. 187, Iss. 11
Closed Access | Times Cited: 62
OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2
Gang Yang, Guangbing Xiong, Mengyu Feng, et al.
Molecular Cancer Research (2020) Vol. 18, Iss. 5, pp. 685-697
Open Access | Times Cited: 61
Gang Yang, Guangbing Xiong, Mengyu Feng, et al.
Molecular Cancer Research (2020) Vol. 18, Iss. 5, pp. 685-697
Open Access | Times Cited: 61
LncRNA NEAT1 facilitates pancreatic cancer growth and metastasis through stabilizing ELF3 mRNA.
Feng Ya-guang, Ling Gao, Guangfei Cui, et al.
PubMed (2020) Vol. 10, Iss. 1, pp. 237-248
Closed Access | Times Cited: 60
Feng Ya-guang, Ling Gao, Guangfei Cui, et al.
PubMed (2020) Vol. 10, Iss. 1, pp. 237-248
Closed Access | Times Cited: 60